World's Best Scientists 2026 revealed!

D-Index & Metrics

Genetics

D-Index
65
Citations
13685
World Ranking
2713
National Ranking
1190

Overview

Ludwine Messiaen is affiliated with the University of Alabama at Birmingham in the United States. Their research primarily focuses on neurofibromatosis and related genetic conditions, with a significant body of work exploring diagnostic criteria and molecular mechanisms involved in these disorders.

The scientist has contributed extensively to the fields of Medicine and Biochemistry, Genetics and Molecular Biology. Within these, their research emphasizes subfields such as Neurology, Molecular Biology, Rheumatology, Epidemiology, and Pulmonary and Respiratory Medicine.

Key topics covered in their work include:

  • Neurofibromatosis and Schwannoma Cases
  • Chromatin Remodeling and Cancer
  • Meningioma and Schwannoma Management
  • RNA Modifications and Cancer
  • Neuroblastoma Research and Treatments
  • Sarcoma Diagnosis and Treatment
  • Peptidase Inhibition and Analysis

Frequent collaborators with significant joint publications include:

  • Eric Legius
  • Alicia Gomes
  • D. Gareth Evans
  • P. Wolkenstein
  • David A. Stevenson

Ludwine Messiaen has published multiple articles in prominent venues, with a strong presence in Genetics in Medicine and Human Mutation. Other publication venues include Neurology, Molecular Therapy - Nucleic Acids, and the European Journal of Human Genetics.

Notable papers authored or co-authored by Messiaen include:

  • "Revised diagnostic criteria for neurofibromatosis type 1 and Legius syndrome: an international consensus recommendation" (2021, Genetics in Medicine)
  • "Updated diagnostic criteria and nomenclature for neurofibromatosis type 2 and schwannomatosis: An international consensus recommendation" (2022, Genetics in Medicine)
  • "AG-exclusion zone revisited: Lessons to learn from 91 intronic NF1 3' splice site mutations outside the canonical AG-dinucleotides" (2020, Human Mutation)
  • "Targeted exon skipping of NF1 exon 17 as a therapeutic for neurofibromatosis type I" (2022, Molecular Therapy - Nucleic Acids)
  • "Natural history of NF1 c.2970_2972del p.(Met992del): confirmation of a low risk of complications in a longitudinal study" (2021, European Journal of Human Genetics)

Best Publications

  • Exhaustive mutation analysis of the NF1 gene allows identification of 95% of mutations and reveals a high frequency of unusual splicing defects.

    Ludwine M. Messiaen;Tom Callens;Geert Mortier;Diane Beysen

  • Germline loss-of-function mutations in SPRED1 cause a neurofibromatosis 1-like phenotype.

    Hilde Brems;Magdalena Chmara;Magdalena Chmara;Mourad Sahbatou;Ellen Denayer

  • Revised diagnostic criteria for neurofibromatosis type 1 and Legius syndrome: an international consensus recommendation.

    E Legius;L Messiaen;P Wolkenstein;P Pancza

  • An absence of cutaneous neurofibromas associated with a 3-bp inframe deletion in Exon 17 of the NF1 gene (c.2970-2972 delAAT): evidence of a clinically significant NF1 genotype-phenotype correlation

    M. Upadhyaya;S. M. Huson;M. Davies;N. Thomas

  • Evolution and expression of FOXL2

    J Cocquet;E Pailhoux;F Jaubert;N Servel

  • Spectrum of FOXL2 gene mutations in blepharophimosis-ptosis-epicanthus inversus (BPES) families demonstrates a genotype–phenotype correlation

    Elfride De Baere;Michael J. Dixon;Kent W. Small;Ethylin W. Jabs

  • FOXL2 and BPES: Mutational hotspots, phenotypic variability, and revision of the genotype-phenotype correlation

    Elfride De Baere;Diane Beysen;Christine Oley;Birgit Lorenz

  • Elucidating distinct roles for NF1 in melanomagenesis.

    Ophélia Maertens;Bryan Johnson;Bryan Johnson;Pablo Hollstein;Pablo Hollstein;Dennie T. Frederick

  • Germline loss-of-function mutations in LZTR1 predispose to an inherited disorder of multiple schwannomas

    Arkadiusz Piotrowski;Arkadiusz Piotrowski;Jing Xie;Ying F Liu;Andrzej B Poplawski

  • Molecular pathogenesis of multiple gastrointestinal stromal tumors in NF1 patients

    Ophélia Maertens;Hans Prenen;Maria Debiec-Rychter;Agnieszka Wozniak

  • Mutations of VMD2 Splicing Regulators Cause Nanophthalmos and Autosomal Dominant Vitreoretinochoroidopathy (ADVIRC)

    Jill Yardley;Bart P Leroy;Niki Hart-Holden;Bart A Lafaut

  • NF1 Is a Tumor Suppressor in Neuroblastoma that Determines Retinoic Acid Response and Disease Outcome

    Michael Hölzel;Sidong Huang;Jan Koster;Ingrid Øra

  • Clinical and mutational spectrum of neurofibromatosis type 1-like syndrome.

    Ludwine Messiaen;Suxia Yao;Hilde Brems;Tom Callens

  • High Incidence of Noonan Syndrome Features Including Short Stature and Pulmonic Stenosis in Patients carrying NF1 Missense Mutations Affecting p.Arg1809: Genotype-Phenotype Correlation.

    Kitiwan Rojnueangnit;Kitiwan Rojnueangnit;Jing Xie;Alicia Gomes;Angela Sharp

  • Genotype-Phenotype Correlation in NF1: Evidence for a More Severe Phenotype Associated with Missense Mutations Affecting NF1 Codons 844–848

    Magdalena Koczkowska;Yunjia Chen;Tom Callens;Alicia Gomes

  • Update from the 2011 International Schwannomatosis Workshop: From genetics to diagnostic criteria.

    Scott Randall Plotkin;Jaishri O. Blakeley;D. Gareth Evans;C. Oliver Hanemann

  • Molecular dissection of isolated disease features in mosaic neurofibromatosis type 1.

    Ophélia Maertens;Sofie De Schepper;Jo Vandesompele;Hilde Brems

  • Quantification of splice variants using real-time PCR

    Ina I. Vandenbroucke;Jo Vandesompele;Anne De Paepe;Ludwine Messiaen

  • Proteasomal and Genetic Inactivation of the NF1 Tumor Suppressor in Gliomagenesis

    Lauren T. McGillicuddy;Lauren T. McGillicuddy;Jody A. Fromm;Jody A. Fromm;Pablo E. Hollstein;Pablo E. Hollstein;Sara Kubek

  • Double Inactivation of NF1 in Tibial Pseudarthrosis

    David A. Stevenson;David A. Stevenson;Holly Zhou;Shadi Ashrafi;Ludwine M. Messiaen

Frequent Co-Authors

Anne De Paepe
Anne De Paepe Ghent University Hospital
Kathleen Claes
Kathleen Claes Ghent University Hospital
Eric Legius
Eric Legius KU Leuven
Bruce R. Korf
Bruce R. Korf University of Alabama at Birmingham
Meena Upadhyaya
Meena Upadhyaya Cardiff University
Hildegard Kehrer-Sawatzki
Hildegard Kehrer-Sawatzki University of Ulm
Franki Speleman
Franki Speleman Ghent University
Geert Mortier
Geert Mortier University of Antwerp
Elfride De Baere
Elfride De Baere Ghent University
David Neil Cooper
David Neil Cooper Cardiff University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring Genetics in the USA opens doors to a variety of online degrees and career options in healthcare and life sciences. If you’re interested in patient care, consider accredited nursing schools without teas test requirements, which streamline the application process and get you started sooner.

For those seeking fast entry into the workforce, a 6 months lpn program can provide practical nursing skills in less than a year. If you have ambitions for leadership or hospital administration, you might explore mha online programs—these master’s programs are flexible and affordable, ideal for busy professionals.

For those interested in advancing research or academic careers, there are also options for an online nursing doctorate, which can prepare you for top roles in teaching or clinical research. Each pathway offers unique opportunities for specialization and career growth alongside genetics.

Best Scientists Citing Ludwine Messiaen

Trending Scientists

Recently Published Articles